What lies in the future for genomics and big data?

<p class="MsoNormal"><span style= "mso-ascii-font-family: Calibri; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri;"> Today’s episode is titled, “What lies in the future for genomics and big data?", which covers two articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “<a href= "https://www.ddw-online.com/whats-the-next-step-in-big-data-and-ai-17898-202207/">What’s the next step in big data and AI?</a>” and “<a href= "https://www.ddw-online.com/why-a-recent-advancement-is-a-giant-leap-for-human-genomics-17872-202207/">Why a recent advancement is a giant leap for human genomics</a>”.</span></p> <p class="MsoNormal"><span style= "mso-ascii-font-family: Calibri; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri;"> In the first article, Troy Groetken of intellectual property and technology law firm McAndrews, Held & Malloy tells Lu Rahman how pharma companies can take this data from where it currently stands (drug design and development) to a more clinical level.</span><span style= "mso-ascii-font-family: Calibri; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri;"> </span></p> <p class="MsoNormal"><span style= "mso-ascii-font-family: Calibri; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri;"> In the second article, Dr Oyvind Dahle and Michael Pontrelli from Foley & Lardner LLP, talk about the first complete, gapless sequence of a human genome, which was published on 1 April 2022 in a special issue of the journal <em>Science</em>.</span></p>